ICH E2E: Pharmacovigilance Planning Membership of the ICH Points to Consider Working Group Current members of the ICH Points to Consider Working Group Affiliation Member Maria Luisa Casini Commission of the European Communities Kavita Chadda Hilary Vass* European Federation of Pharmaceutical Industries and Associations Christina Winter† Alison Bennett Health Canada Polina Ostrovsky Lynn Macdonald Yutaka Nagao Kazuyuki Sekiguchi Japanese Maintenance Organization Mitsuru Takano Reiji Tezuka Yo Tanaka Japan Pharmaceutical Manufacturers Association Hitomi Takeshita MedDRA MSSO Judy Harrison Yuhei Fukuta Miki Ohta Ministry of Health, Labour and Welfare/Pharmaceuticals and Medical Daisuke Sato Devices Agency Makiko Isozaki Kiyomi Ueno Milbhor D’Silva Pharmaceutical Research and Manufacturers of America JoAnn Medbery US Food and Drug Administration Sonja Brajovic#
ICH E2E: Pharmacovigilance Planning Membership of the ICH Points to Consider Working Group Current members of the ICH Points to Consider Working Group Affiliation Member Commission of the European Communities Maria Luisa Casini Kavita Chadda European Federation of Pharmaceutical Industries and Associations Hilary Vass* Christina Winter† Health Canada Alison Bennett Polina Ostrovsky Lynn Macdonald Japanese Maintenance Organization Yutaka Nagao Kazuyuki Sekiguchi Mitsuru Takano Reiji Tezuka Japan Pharmaceutical Manufacturers Association Yo Tanaka Hitomi Takeshita MedDRA MSSO Judy Harrison Ministry of Health, Labour and Welfare/Pharmaceuticals and Medical Devices Agency Yuhei Fukuta Miki Ohta Daisuke Sato Makiko Isozaki Kiyomi Ueno Pharmaceutical Research and Manufacturers of America Milbhor D’Silva JoAnn Medbery US Food and Drug Administration Sonja Brajovic#
9610-1800_datretptc_r3_9_mar2015_0.docx